IEQ Capital’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding HRTX
IEQ Capital's HRTX Position: Q3 2026 in Review
IEQ Capital reduced its Heron Therapeutics (HRTX) stake by 11% in Q3 2026, selling an estimated $4.06K and leaving 85,899 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1935.
IEQ Capital first reported a position in HRTX in Q3 2025 and has held it in 5 quarters since. The position peaked at $100K in Q3 2025. 158 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.
- IEQ Capital held 85,899 shares of Heron Therapeutics worth $26.9K as of Q3 2026.
- IEQ Capital sold 10,713 Heron Therapeutics shares in Q3 2026, an estimated $4.06K.
- Heron Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q3 2026, its #1935 holding.
- IEQ Capital first reported a position in Heron Therapeutics in Q3 2025 and has held it in 5 quarters since.
- IEQ Capital's Heron Therapeutics position peaked at $100K in Q3 2025.
- 158 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.
Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.